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Dengue virus (DENV) infection was reported by more than 100 countries in the world. DENV was estimated
infects 2.5 billion people living at tropical and subtropical countries annually. Laboratory diagnosis of DENV
infection is important for the best clinical management of the patients. There are many tools and methods
have been developed and dedicated to serve accurate diagnostic of DENV infection. In hitherto, laboratory
diagnosis of DENV infection may be done by several methods, i.e. serology, viral culture, and viral genome-
based detection. However, there is no convincing diagnosis procedures that easy to be performed and user
friendly. This review will address the principle and characteristic of the laboratory diagnostic procedures
that is available at this moment.
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INTISARI
Infeksi virus Dengue (DENV) dilaporkan oleh lebih dari 100 negara di dunia. Setiap tahunnya, DENV diperkirakan
menginfeksi 2,5 miliar orang yang tinggal di negara-negara tropis dan subtropis. Diagnosis laboratorium infeksi
DENV penting bagi pengelolaan klinis terbaik bagi pasien. Terdapat banyak alat dan metode yang telah
dikembangkan dan didedikasikan untuk memberikan pelayanan diagnostik infeksi DENV yang akurat. Sampai
sekarang, diagnosis laboratorium infeksi DENV dapat dilakukan dengan beberapa metode, yaitu serologi,
kultur virus, dan deteksi berbasis genom virus. Namun, tidak ada prosedur diagnosis yang meyakinkan, mudah
untuk dilakukan dan user friendly. Review ini akan membahas prinsip dan karakteristik dari prosedur diagnostik
laboratorium yang tersedia pada saat ini.
Kata kunci: virus Dengue, infeksi, uji laboratorium, diagnosis
INTRODUCTION
Dengue virus (DENV) infection was
reported by more than 100 countries in the
world. DENV was estimated infects 2.5 billion
people living at tropical and subtropical
countries annually. The DENV infection also
involves 120 million travelers to these particular
countries1. WHO claimed that 100 million
peoples infected by DENV annually. As much
as 500.000 people have developed dengue
hemorrhagic fever which were need medical
attention, most of them are children2.
DENV infection has broad spectrum of
clinical manifestation. Traditionally, it was
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classified into three major group of clinical
manifestation: i.e. dengue fever, dengue
hemorrhagic fever and dengue shock syndrome3.
Later on, this classification was revised in 2009.
There are many debates about the effectiveness
of the two classification of DENV infection clinical
classification in the field and clinic4.
Dengue fever (DF) is a mildest syndrome
which characterized by biphasic fever, myalgia
or athragia, rash, leucopenia and lymphadeno-
phaty. Dengue hemorrhagic fever (DHF) is a worst
clinical manifestation compare to DF. DHF may
be fatal that shown haemostatic and capillary
permeability disturbance. DHF may be worsen
and become dengue shock syndrome (DSS)5. DSS
contributes to 1-2.5% mortality rate with proper
medical attention and dramatically increase to
20% in poor patient management setting3.
Dengue virus (DENV) infection is remained
the most frequent arboviral infection globally.
DENV is consisting of four serotypes: i.e. DENV1,
DENV2, DENV3, and DENV4. These four serotypes
are circulating globally. There is no specific
geographical region associated with particular
serotypes. Indonesia as well as other country
has been reported all those four serotypes as
causative agents of dengue virus infection2.
DENV is included into flaviviridae family,
genus flavivirus. Though it is common to be
describe as four serotypes DENV1, DENV2,
DENV3, and DENV4, some researcher think that
this nomenclature is not completely describe the
fact. The four serotypes of DENV are antigenic
and genetically distinct among each other. It is
unlike polio virus with three serotypes. DENV
may be described as four different viruses that
potentially cause similar diseases in the human
being6.
DENV genetically is close related with other
flavivirus, i.e. Japanese encephalitis and tick-
borne encephalitis serogroups, the non-vector-
borne viruses Rio Bravo, Montana myotis
leukoencephalitis, Modoc, Tamana bat and Apoi.
Japanese encephalitis serogroup may cause
similar disease in human, encephalitis. This
group includes Murray Valley encephalitis virus
(MVEV) which is circulating in Australia, St. Louis
encephalitis virus (SLEV) in America, Japanese
encephalitis virus (JEV) in Asia, and West Nile
virus (WNV) that is broadly circulating in Africa,
America, Europe and Middle East6. Box 1 shows
the representative arboviruses of flaviviridae
that commonly cause human diseases.
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DENV virion consists of single strand RNA
which is encapsulated with icosahedral or
isometric nucleocapsid. The most outer part
of the DENV virion is envelope structure. DENV
has approximately 50 nm in diameter. The
genome of DENV consists of single open
reading frame (ORF) gene which encodes three
Figure 1. The schematic structure of DENV genome and translation
process which will produce single polypetptide that eventually
cleaved by signal peptidase, golgy protease and NS3 protease.
The different colors denote the putative cleavage sites of
proteases (modified from http://viralzone.expasy.org/
all_by_species/43.html).
structural protein (PrM, C, and E) and seven
non structural proteins (NS1, NS2a, NS2b, NS3,
NS4a, NS4b, and NS5). The whole genome is
translated into a polyprotein, which is
processed co- and post-translationally by host
and viral proteases (Figure 1)7.
Laboratory diagnosis of DENV infection is
not conclusive yet. There are many tools and
methods have been developed and dedicated
to serve accurate diagnostic of DENV infection.
In hitherto, laboratory diagnosis of DENV
infection may be done by several methods,
i.e. serology, viral culture, and viral genome-
based detection. However, there is no
convincing diagnosis procedures that easy to
be performed and user friendly. This review
will address the principle and characteristic
of the diagnostic procedures that is available
at this moment.
Diagnosis of DENV Infection
DENV is present in the saliva of mosquito
and injected into the skin tissue of human being.
Injected DENV virion binds and replicates in the
dendritic cells of the skin. DENV further
replicates and transfer into the lymphoid tissues
and viremia will be occur 3-5 days later. Viremia
will be finished at the 4th - 5 th day. The
symptoms, including fever, start to appear 24
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techniques. Monoclonal antibody against
specific DENV serotype will able to recognize the
presence of DENV in the cell culture. Mammalian
cell which is commonly used for DENV isolation
is Vero, LLCMK2, and BHK21. However, the
mammalian cell is less superior compare to
mosquito cell lines12.
Specimen from the patient may directly
being inoculated intracerebrally to suckling mice.
The presence of DENV can be detected by
behavioral change of mice. Immunofluorescence
detection of suckling mice brain is also possible
to visualize the DENV. This method has several
disadvantages, including high cost, long time for
isolation, and low sensitivity. These
disadvantages have prevented further
recommendation of this method for DENV
isolation12.
The last method available to isolate DENV
is direct inoculation into live mosquito.
Specimen can be injected intra-thorax into the
mosquito. Several mosquito are commonly used
for this purpose i.e. Toxorhynchites splendens,
Aedes albopictus, and Aedes aegypti.
Toxorhynchites splendens is the most common
use because of its extra large size, easy to be
inoculated, and it does not need blood for live.
To detect the inoculated DENV in the mosquito
we can use the head squash immunostaining
using monoclonal antibody against DENV. This
method is superior compare to the cell culture
inoculation and even comparable to the RT-PCR
method2,8,13.
2. Nucleic acid based detection
RT-PCR
Reverse transcriptase-polymerase chain
reaction (RT-PCR) for dengue virus detection was
developed since 1990. RT- PCR is a useful
hours after viremia onset. The time frame of
DENV infection is important to understand the
laboratory diagnostic methods that are
applicable to detect DENV infection8. Box 2
shows the current diagnostic tools that available
to detect DENV infection.
1. DENV Isolation
For viral isolation purpose, the specimen
should be obtained in the very beginning of
infection, since viremia occurs before the 5th day
post infection. DENV may be isolated from
serum, plasma or peripheral blood mononuclear
cells (PBMCs). Specimen for viral isolation in
certain cases may be obtained from post
mortem tissue biopsy i.e. liver, lung, lymph
nodes, thymus, and bone marrow9. Since DENV
is sensitive to temperature, specimen must be
transfer to the laboratory in ice pack to maintain
the cold chain. It may be stored at 4p C-8p C for
less than 24 hours. For longer preservation, it
may be stored at -70p C or in the liquid nitrogen.
It is not recommended to store at -20p C3.
The most common method to isolate DENV
is by infected to cells. The mosquito origins cell
line which is routinely used for this purpose is
C6/36, a cell line that obtained from Ae
albopictus10. Another cell line is from Ae.
pseudoscutellaris, namely AP6111. Morphological
changes in cells caused by viral infection are
called cytopathic effects (CPE). The presence of
DENV in the clinical specimen can be seen by
observing the cytopathic effect in the cell lines.
The degree of visible damage to cells caused by
viral infection varies with type of virus, type of
host cells, multiplicity of infection (MOI), and
other factors. Some cell will die because of being
infected by DENV. However, Cytopathic effect of
DENV to the mosquito origin cell line sometimes
not easy to be seen. To detect DENV in the cell
lines we may use immune-fluorescence
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method for dengue diagnosis, but it still needs
to be better standardized. There are various
methods and primer correspond to certain
specific region of DENV genome had been
developed. These methods need to be
standardized to have optimum validity. The basic
principle of the method is conversion of RNA of
DENV to cDNA by using reverse transcripatase
enzymes. The cDNA then is subjected to PCR
amplification. If specific nucleotide sequence
succeeds to be amplified using specific primer,
it would be considered as positive result.
RNA based detection of DENV was started
by using nested RT-PCR approach14. Universal
primers correspond to C/prM gene of DENV
genome were employed for the first round
amplification. Then, specific serotype
amplification was performed using nested PCR
strategy. One step multiplex RT-PCR was
developed by Harris et al.15. One universal
primer and four serotypes specific primers were
employed for DENV serotypes detection
purpose. DENV Serotypes were recognized by
different band expected size in electrophoresis
assay after amplification.
The DENV RT-PCR assay provides a rapid,
sensitive, diagnostic tool for detecting DENV in
specimens from infected individuals. There are
several limitation on the application of RT-PCR
to the diagnosis of DENV: RT-PCR only suitable
to detect the acute phase samples. RT-PCR need
specific well equipped laboratory, such as
ultracentrifuge, thermocycler and electro-
phoresis apparatus8. This technique also needs
well trained laboratory technician.
RT-PCR sensitivity was 80%-100% compared
to virus isolation method. The variable sensitivity
might be caused by different primer being used
and target genome of the DENV. There are two
variations of RT-PCR methods: one step RT-PCR
and two step RT-PCR2.
Real Time RT-PCR
Standard RT-PCR will indicate positive if a
particular nucleotide sequence is present in the
clinical specimens. However, sometimes the
clinician is also interested in the amount of the
target sequence present in the specimen16. Real
time RT-PCR is a technique that is sufficient to
detect and count the RNA of virus in particular
specimen.
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There are many RT-PCR protocols have been
developed. The protocols are using Taq Man real
time RT-PCR or SYBRGreen real time RT-PCR. The
Taq Man real time RT-PCR is considered more
specific compare to SYBRGreen real time RT-PCR2,
17. Real time RT-PCR may be used singleplex or
multiplex approach. The first is using only primer
which corresponds to one DENV serotypes. The
multiplex approach is employed several primers
which correspond to more than one DENV
serotypes2,18,19.
The advantage of real time RT-PCR is
superior in diagnosis of DENV infection in clinical
setting. Real time RT-PCR Assay had been shown
sensitivity of 97.65%, specificity was 92.59% and
accuracy was 95.82% when compared to
conventional RT-PCR. Moreover, there was no
cross-reaction between chikungunya virus
(CHIKV), DENV, Japanese encephalitis virus,
hepatitis C, hepatitis A or hepatitis E virus. The
data were obtained from 290 suspected
individuals20. These data indicated that real time
RT-PCR method provides a reliable diagnostic
for DENV infection. However, the real time RT-
PCR method is not recommended in the
institution with limited resources. This
technology is demanded high cost-sophisticated
equipments and reagents.
3. DENV Antigen Detection
Detection of DENV infection may be made
use of surrogate biomarker such as viral antigen.
One of remarkable succeed of biomarker
identification is the NS1 of DENV which is a non
structural protein. NS1 can be utilized to detect
DENV in viremia stage, since cellular infection
with ENV results in the production and release
of the nonstructural protein NS-1. A series of
1,055 samples were analyzed by the NS1 test
and using virus isolation as gold standard. As
much as 790 samples were NS1-positive and 726
of these were positive for virus isolation. The
agreement between these two assays was 91.9%.
Among the 265 NS1-negative samples, there
were 13 positive virus isolations (4.9% of false
NS1-negative)21. This method is a promising for
further development. NS1 detection assay has
been shown to be inexpensive, high throughput
and easy to performed in the field.
NS1 is produced by DENV and localized at
the cell surface, which eventually released in to
the blood stream. The half-life of NS1 antigen in
the blood of infected patients is longer than that
of intact virus and has been detected in sera up
to18 days after the onset of symptoms, with
peak antigen detected at days 6–10 after the
onset of fever8, 22. Enzyme link immunosorband
assay (ELISA) and rapid test immunochromato-
graphy based technology have been develop for
NS1 antigen detection assay. These two
technology offer good approach for DENV
infection detection23. The accuracy of the Platelia
NS1 ELISA assay and an NS1 lateral flow rapid
test (LFRT) were compared against a gold
standard reference diagnostic algorithm in 138
Vietnamese children and adults. The Platelia NS1
ELISA was modestly more sensitive (82%) than
the NS1 LFRT (72%) in confirmed DENV infection
cases24.
4. Serology
Serological assays for DENV infection
includes: Hemagglutination inhibition (HI) assay,
Plaque reduction neutralization test (PRNT),
Enzyme immunosorbent assays (EIA’s), Indirect
fluorescent antibody (IFA) test, western blott,
and rapid detection assay
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Hemagglutination inhibition (HI) assay
The haemagglutination-inhibition (HI) assay
is based on the ability of DENV antigens to
agglutinate red blood cells (RBC) of ganders or
trypsinized human O RBC. DENV antigen is able
to agglutinate normal erythrocytes and the
complex will precipitate at the bottom of wells
after 30-60 minutes8. Anti-dengue antibodies in
sera of the patients can inhibit this agglutination
Figure 2. (A) Negative result: DENV antigens able to agglutinate the red blood
cells and precipitates in the bottom of the wells. (B) Positive result:
The anti-DENV antibodies which is presence in the patients sera
inhibit the agglutination process
and the potency of this inhibition is measured
in an HI assay2. Inhibition by the antibody in the
sera will give specific bottom like appearance in
the wells (Figure 2). The titer of antibody is
defined by the lowest concentration which is
shown to have inhibition of hemaglutination.
WHO has released the guideline for
interpretation of the HI assay in dengue virus
infection cases (table 1)3.
HI assay has been the most widely used
method for the serological diagnosis of dengue
infection in the past. However, due to the
nature of HI assay: extensive cross-reaction of
all flaviviruses25, time consuming, also the
requirement of both acute and convalescent
sera collected at least seven days apart have
reduced the general applicability of this
assay2.
HI assays is recommended to distinguish the
primary and secondary DENV infection3.
However, recently there are many novel
techniques available for this purpose26.
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Plaque reduction neutralization test (PRNT)
PRNT was introduced in 1967 by Russel and
Nisalak and able to measure the antibodies
serotypes specific titers27. PRNT is considered as
the most specific serology method to detect
DENV infection. This method may be employed
to detect DENV serotype in the sera at the
convalescent period. PRNT measures the titer
of the neutralizing antibodies in the sera of DENV
infected patients and determines the level of
protective antibodies of the particular individual.
towards the virus. The assay is a biological assay
based on the principle of interaction of virus
and antibody resulting in inactivation of virus.
The virus ability to infect and replicate in cell
culture was diminished28.
PRNT is a gold standard for antibody against
DENV titer measurement. Since the first method
developed by Russell and Nisalak, there are
many modification which is employed different
cell lines, virus preparation, and the presence
or absence of complement. Modification of
these conditions had significant effects on the
PRNT titers measured in a particular serum
sample. Significant associations were observed
between testing conditions and titers measured
from different tests on the same serum sample29.
Base on this finding, very careful standardization
PRNT method is highly demanded in clinical
microbiology laboratory serving for dengue virus
infection diagnostic tests
MAC-ELISA
IgM antibody-capture enzyme immunosor-
bent assay (MAC-ELISA) can be used to measure
IgM total in patients serum. MAC-ELISA is the
most common method employed in diagnostic
laboratories and commercial available diagnostic
kits. The assay is based on capturing human IgM
antibodies on a microtiter plate using anti-
human-IgM antibody followed by the addition
of dengue virus specific antigen (DENV1-4). The
antigens used for this assay are derived from
mainly envelope protein of the virus. Specific
antigen of DENV1, DENV2, DENV3, or DENV4 will
Tabel 1. WHO guideline for HI assay interpretation in dengue virus infection cases3
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bind to the IgM anti dengue which is present in
the patients serum28.
MAC-ELISA can be used for IgM against
DENV detection from serum, whole blood on
filter paper, and saliva, but not the urine, which
obtained more than five days from first onset
of fever. MAC-ELISA has high specificity and
sensitivity. Different commercial kits are available
but have variable sensitivity and specifi city2.
The pitfall of this method is the cross
reactivity between DENV and other diseases i.e.
malaria, leptospirosis and previous DENV
infection, though cross-reactivity with other
circulating flaviviruses such as Japanese
encephalitis, St Louis encephalitis and yellow
fever, does not seem to be a problem2.
IgG ELISA
The IgG ELISA test is being used for the
detection of a past infection of DENV. The
antigens of DENV are employed in this assay,
exactly similar with MAC-ELISA. The assay is
usually performed with serial dilutions of the
sera of the patients. The aim is to determine an
end-point dilution. In general, IgG ELISA has low
specificity within the flavivirus sero-complex
groups9.
IgG against DENV may be presence lifelong
in the patients serum. However, fourfold or
greater elevation of IgG titer between the
convalescent and acute phase may be indicated
of present DENV infection2. (WHO, 2009). IgG-
ELISA is comparable to the HI assay in term of it
can be used for the differentiation of primary
and secondary DENV infections30.
CONCLUSION
The available laboratory assays have been
shown to be good to provide platform of the
DENV infection diagnosis in the clinical and field
setting. However, laboratory assays as tools for
DENV infection detection needs to be further
developed. The ideal laboratory diagnosis
method which is user friendly, cost effective,
accurate and robust is needed for DENV infection
detection.
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